Beam Therapeutics Inc. (BEAM) Operating margin 2019–2025
Beam Therapeutics Inc. (BEAM) operating margin by fiscal year — reported operating income divided by reported revenue.
-274.6%FY2025 · since FY2019: -417522.2% → -274.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -274.6% | +379.7 pp |
| FY2024 | -654.3% | -607.5 pp |
| FY2023 | -46.7% | +508.9 pp |
| FY2022 | -555.6% | +201.4 pp |
| FY2021 | -757.0% | +552409.7 pp |
| FY2020 | -553166.7% | -135644.4 pp |
| FY2019 | -417522.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BEAM financial trends
BEAM RevenueBEAM Net incomeBEAM Net marginBEAM Gross profitBEAM Gross marginBEAM Operating incomeBEAM Operating cash flowBEAM Free cash flowBEAM Capital expendituresBEAM Return on equityBEAM Stock buybacksBEAM Dividends paidBEAM Total assetsBEAM Total liabilitiesBEAM Shareholders’ equityBEAM overview →